March 2014. Volume 10. Number 1

Examen clínico en el diagnóstico de hiperbilirrubinemia neonatal, ¿una estrategia de cribado válida en Atención Primaria?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AAP | Making well-informed clinical decisions based on the current scientific evidence: from the article to the patient

Author: Trobbiani JI1.
1Departamento de Ciencias de la Salud, Universidad Nacional del Sur. Bahía Blanca. Buenos Aires. Argentina.
Correspondence: Juan Ignacio Trobbiani. Email: juaniitrobbiani@gmail.com
Reception date: 11/10/2013
Acceptance date: 20/12/2013
Publication date: 22/01/2013

Abstract

Authors’ conclusions: the accuracy of clinical tools for predicting significant neonatal hyperbilirubinemia is comparable (although not better) to predischarge transcutaneous bilirubin measurement. Neonatal risk of developing significative hyperbilirrubinemia can be assessed simply and accurately by using a combination of predischarge transcutaneous bilirrubin determination and gestational age.

Reviewers’ commentary: present study results are framed in a global debate on the utility and effectiveness of neonatal hyperbilirubinemia screening. In primary care environments, by means of a combined screening approach, neonatal hyperbilirubinemia’s development risk can be estimated with acceptable accuracy in order to define course of action on a rational basis.

How to cite this article

Trobbiani JI. Examen clínico en el diagnóstico de hiperbilirrubinemia neonatal, ¿una estrategia de cribado válida en Atención Primaria? Evid Pediatr. 2014;10:3.

AAP | Making well-informed clinical decisions based on the current scientific evidence: from the article to the patient

Author: Trobbiani JI1.
1Departamento de Ciencias de la Salud, Universidad Nacional del Sur. Bahía Blanca. Buenos Aires. Argentina.
Correspondence: Juan Ignacio Trobbiani. Email: juaniitrobbiani@gmail.com
Reception date: 11/10/2013
Acceptance date: 20/12/2013
Publication date: 22/01/2013

Sorry, there is no English version for this item.

How to cite this article

Trobbiani JI. Examen clínico en el diagnóstico de hiperbilirrubinemia neonatal, ¿una estrategia de cribado válida en Atención Primaria? Evid Pediatr. 2014;10:3.

References

  1. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. 2008;121:e170-9.
  2. Rodríguez Miguélez JM, Aloy JF. Ictericia neonatal. En: Protocolos Diagnóstico Terapeúticos de la AEP: Neonatología; 2008. p. 372-83 [en línea] [consultado el 21/11/2013]. Disponible en www.aeped.es/protocolos/
  3. Ceriani Cernadas JM. Ictericia neonatal. En: Neonatología Práctica, 4.ª ed. Buenos Aires: Editorial Médica Panamericana; 2009. p. 545-74.
  4. Johnson L, Bhutani VK. The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Perinatol. 2011;35:101-13.
  5. The guide to clinical preventive services 2012: recommendations of the U.S. preventive services task force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012; p. 64 [en línea] [consultado el 21/11/2013]. Disponible en http://www.ncbi.nlm.nih.gov/books/NBK115115/
  6. National collaborating centre for women's and children's health.Neonatal jaundice. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010. p. 53 [en línea] [consultado el 21/11/2013]. Disponible en http://www.ncbi.nlm.nih.gov/books/NBK65113/#ch2.s1
  7. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or = 35 weeks’ gestation: an update with clarifications. Pediatrics. 2009;124:1193-8.
  8. Newman TB. Universal bilirubin screening, guidelines, and evidence. Pediatrics. 2009;124:1199-202.
  9. Wong RJ, Butani VK. Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants. En UpToDate [en línea]. Disponible en www.uptodate.com
  10. Fernández Rodríguez M, Martín Muñoz P. La valoración clínica de la ictericia no es buen método para el cribado de hiperbilirrubinemia neonatal. Evid Pediatr. 2008;4:77.
  11. Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child. 1969;118:454-8.
  12. Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med. 2000;154:391-4.
  13. Riskin A, Tamir A, Kugelman A, Hemo M, Bader D. Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia? J Pediatr. 2008;152:782-7.
  14. Newman TB, Liljestrand P, Escobar GJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med. 2005;159:113-9.
  15. Wickremasinghe AC, Karon BS, Cook WJ. Accuracy of neonatal transcutaneous bilirubin measurement in the outpatient setting. Clin Pediatr (Phila). 2011;50:1144-9.
  16. Keren R, Bhutani V, Luan X, Nihtianova S, Cnaan a, Schwartz J. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child. 2005;90:415-21.
  17. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297-316.
22/01/2013

Linked Comment